IDI1 inhibits the cGAS-Sting signaling pathway in hepatocellular carcinoma

IDI1 inhibits the cGAS-Sting signaling pathway in hepatocellular carcinoma

Metabolic reprogramming is one of the prominent features that distinguishes tumor cells from normal cells. The role of metabolic abnormalities in regulating innate immunity is poorly understood. In this study, we found that IDI1 is significantly upregulated in liver cancer. IDI1 has no significant e...

Full description

Bibliographic Details
Main Authors: Lin Fu, Hui Ding, Yangqiu Bai, Lina Cheng, Shanshan Hu, Qiongya Guo
Format: Article
Language:English
Published: Elsevier 2024-03-01
Series:Heliyon
Subjects:
Hepatocellular carcinoma
IDI1
cGAS
TRIM41
Online Access:http://www.sciencedirect.com/science/article/pii/S2405844024032365

Similar Items

Similar Items